Johnson & Johnson Headquarters.

Johnson & Johnson was sued by an employee who said the company's health plan wasted workers' money by paying inflated prices for prescription drugs.

In one instance, the health plan agreed to pay more than $10,000 for a drug to treat multiple sclerosis, a chronic nerve condition, that's available for as little as $40 at retail pharmacies, according to the suit filed Monday in federal court in Camden, New Jersey.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Health Care Reform
C-Suite
Cost-Containment
Employee Participation
Employee-Paid
Employer-Paid